IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis

• Lathika Mohanraj ,

  Contributed equally to this work with: Lathika Mohanraj, Ho-Seong Kim, Wei Li

  Affiliation Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, United States of America

  ⨯
• Ho-Seong Kim ,

  Contributed equally to this work with: Lathika Mohanraj, Ho-Seong Kim, Wei Li

  Affiliation Department of Pediatrics, Institute of Endocrinology, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Wei Li ,

  Contributed equally to this work with: Lathika Mohanraj, Ho-Seong Kim, Wei Li

  Affiliation Biocure Pharma LLC, Richmond, Virginia, United States of America

  ⨯
• Qing Cai,

  Affiliation Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, United States of America

  ⨯
• Ki Eun Kim,

  Affiliation Department of Pediatrics, CHA University College of Medicine, Seoul, Korea

  ⨯
• Hye-Jung Shin,

  Affiliation Department of Pediatrics, National Medical Center, Seoul, Korea

  ⨯
• Yong-Jae Lee,

  Affiliation Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Woo Jung Lee,

  Affiliation Department of Pediatrics, Institute of Endocrinology, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Jung Hyun Kim,

  Affiliation Department of Pediatrics, Institute of Endocrinology, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Youngman Oh

  * E-mail: yoh@mcvh-vcu.edu

  Affiliations Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, United States of America, Biocure Pharma LLC, Richmond, Virginia, United States of America

  ⨯